FDA Approves First Treatment for Rare Thyroid Hormone Disorder

(MedPage Today) -- The FDA approved tiratricol (Emcitate) to treat peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency, the agency announced on Monday, marking the first approval for this rare genetic disorder...